Abstract:Stroke is the leading cause of death globally, posing enormous clinical and economic burdens to patients, families, and society.1 According to the American Heart Association/American Stroke Association,2 endovascular thrombectomy (EVT) is standard care for eligible patients with Acute ischemic stroke (AIS) within 6 h of onset. More recent trials suggested that EVT within the 6–24 h windows or even beyond the 24-h window may improve functional outcomes.2-4 However, empirical evidence at different times in a more general population of EVT time window is largely lacking. The objective was to compare the early neurological improvement after EVT in different time windows. The study employed a retrospective cohort study design by using the Bigdata Observatory Platform for Stroke of China (BOSC), which collects data on incident strokes in 31 out of 34 provinces across mainland China.5 We identified adults with a primary diagnosis of AIS who were admitted to the hospital within 7 days of onset and underwent EVT. As described previously,5 trained medical staff collected the following data, including sociodemographics, medical history, and lifestyle factors. The National Institutes of Health Stroke Scale (NIHSS) was administered and evaluated upon hospital admission and discharge. The proportion of patients with early neurological improvement (ENI) was defined as a reduction of ≥4 on the NIHSS after EVT6; early neurological deterioration (END), which was defined as an increase in NIHSS score, was estimated for each time window. The proportions of patients with ENI/END were compared by using the Chi-square tests. Because the distribution of NIHSS score was not normally distributed, the medians with upper and lower quartiles were reported and analyzed with the Mann–Whitney U test. All analyses were conducted using SAS Version 9.4 (SAS Institute, Inc). Two-sided p < 0.05 was considered statistically significant. This study was approved by the ethics committees of the Institutional Review Boards of Minhang Hospital at Fudan University. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. Of the 2105 AIS patients who underwent EVT, 1536 (72.97%) presented at hospitals within 6 h, 402 (19.10%) in 6–12 h, 126 (5.99%) in 12–24 h, and 41 (1.95%) over 24 h (Table 1). The mean age is 64.64 years (SD: 11.96), 1426 (67.74%) were aged under 65 years old. The majority of the study sample were men [1426 (67.74%)] and were from Eastern China [640 (30.40%)]. As for the neurological function, the median reduction in NIHSS score (the improvement of neurological function) was 5.00 [interquartile range (IQR): 0–11.00] for patients presenting within 6 h, 5.00 (IQR: 0–10.00) in 6–12 h, 4.00 (IQR: 0–8.00) in 12–24 h, and 1.00 (IQR: 0–2.00) for over 24 h (Figure 1). The rate of ENI in patients over 24-h time windows was 17.07%, which was only one-third of those among patients arriving within 6 h (58.20%), in 6–12 h (54.73%), and in 12–24 h (52.38%). The proportion of END in patients who underwent EVT over 24 h was 17.07%, which was similar for those who underwent EVT within 24 h. In this nationally representative multi-center analysis of AIS patients, EVT beyond 24 h was associated with early neurological improvement, which is a strong indicator of long-term functional outcomes.6 However, our study reported a much lower proportion of functional improvement, which could be potentially explained by the fact that our findings are based on a more general, representative population in both rural and urban settings across 31 provinces in mainland China, as compared with recently published trials that only focused on specific patients mainly from western countries.3, 4 Furthermore, the current trials measured the 3-month functions, which is generally better than early function upon discharge from the hospital. Compared to EVT within 6 h, which is the time window recommended by the current guideline,2 the late-time window of EVT was associated with fewer improvements in neurological functions. Our study has several limitations. First, patients with missing data were excluded from the analysis, which may lower the generalizability of our findings. Second, some patients and their caregivers may be unable to report the stroke onset time accurately. Our study provides empirical evidence supporting EVT in AIS patients within 24 h of the onset. It also demonstrates the importance of shortening the prehospital delay time but encourages consideration of EVT that is beyond the recommended time window for better neurological improvement in the real world. The authors declare no conflicts of interest. The National Natural Science Foundation of China; CIHR, Grant/Award Number: 81973157, PI: JZ. Natural Science Foundation of Shanghai; CIHR, Grant/Award Number: 17dz2308400, PI: JZ. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Endovascular treatment for acute ischemic stroke beyond the 24-h time window: Selection by target mismatch profile

Endovascular Thrombectomy with or Without Intravenous Alteplase in Acute Stroke

Safety and efficacy of endovascular treatment for acute ischemic stroke of large-vessel occlusion beyond the time window based on imaging evaluation

Late recanalisation beyond 24 hours is associated with worse outcome: an observational study

Endovascular Therapy in Acute Ischemic Stroke: Time is Brain

Endovascular therapy beyond 24 hours for anterior circulation large vessel occlusion or stenosis in acute ischemic stroke: a retrospective study

Endovascular Treatment or General Treatment: How Should Acute Ischemic Stroke Patients Choose to Benefit from Them the Most?

Association between time to treatment and clinical outcomes in endovascular thrombectomy beyond 6 hours without advanced imaging selection

Clinical Outcomes of Endovascular Treatment within 24 Hours in Patients with Mild Ischemic Stroke and Perfusion Imaging Selection.

Endovascular treatment in patients with acute ischemic stroke presenting beyond 6 h after symptom onset: An international multicenter cohort study of the EVA-TRISP collaboration

Abstract TP207: Endovascular Treatment in the Late Time Window: Strict Perfusion Imaging Screening Criteria in Case Selection

Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke

Endovascular Therapy in the Extended Time Window for Large Vessel Occlusion in Patients With Pre-Stroke Disability

Not Too Late to Intervene? A Meta-analysis of 13 Studies Evaluating the Association of Endovascular Therapy with Clinical Outcomes in Stroke Patients Presenting Beyond 24 Hours

Abstract 152: Endovascular Therapy versus Medical Management for Acute Ischemic Stroke With Large Infarct: A Time-Benefit Relationship Analysis

Endovascular therapy versus medical management for ischemic stroke presenting beyond 24 hours: Systematic review and meta-analysis

Safety and Effectiveness Analysis of Endovascular Treatment versus Standard Medication Treatment in Patients with Progressive Acute Ischemic Stroke with Large Vessel Occlusion Stroke in the Ultra-Late Time Window: A Propensity Score Matched Cohort Study

Endovascular treatment over 24 hours after ischemic stroke onset: a single-center retrospective study

Abstract 86: Outcomes of Endovascular Therapy for Late Large Vessel Occlusion in Patients With Pre-Stroke Disability

Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Late-time Window Endovascular Treatment is Associated with Neurological Improvement: Evidence from the National Stroke Registry Data in China